The rate of incarceration for mentally ill patients is climbing as a result of Medicaid tightening control on certain antipsychotic medications, according to a new study. In some states, Medicaid is seeking to contain healthcare costs by requiring physicians to obtain prior authorization before prescribing newer, more costly antipsychotic medications known as atypical antipsychotics.
In a study published this week in The American Journal of Managed Care, researchers compared the rates of incarceration for people with schizophrenia in states which require prior authorization with those who do not. They found that in states requiring prior authorization, someone with schizophrenia has a 22 percent increased risk of being incarcerated.
Read the full story here: